Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KHOURY, S. J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 32

  • Page / 2
Export

Selection :

  • and

Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort studyGAUTHIER, S. A; GLANZ, B. I; BUCKLE, Guy J et al.Journal of the neurological sciences. 2009, Vol 284, Num 1-2, pp 116-119, issn 0022-510X, 4 p.Article

Medulla Oblongata Volume : A Biomarker of Spinal Cord Damage and Disability in Multiple SclerosisLIPTAK, Z; BERGER, A. M; GUTTMANN, C. R. G et al.American journal of neuroradiology. 2008, Vol 29, Num 8, pp 1465-1470, issn 0195-6108, 6 p.Article

Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosisKHOURY, S. J; ORAV, E. J; GUTTMANN, C. R. G et al.Neurology. 1999, Vol 53, Num 4, pp 758-764, issn 0028-3878Article

Defective regulation of IFNγ and IL-12 by endogenous IL-10 in progressive MSBALASHOV, K. E; COMABELLA, M; OHASHI, T et al.Neurology. 2000, Vol 55, Num 2, pp 192-198, issn 0028-3878Article

Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patientsTAKASHIMA, H; SMITH, D. R; FUKAURA, H et al.Clinical immunology and immunopathology (Print). 1998, Vol 88, Num 1, pp 28-34, issn 0090-1229Article

Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptideKHOURY, S. J; SAYEGH, M. H; HANCOCK, W. W et al.The Journal of experimental medicine. 1993, Vol 178, Num 2, pp 559-566, issn 0022-1007Article

Characterization of immunomodulatory properties and accessory cell function of small intestinal epithelial cellsSANTOS, L. M. B; LIDER, O; AUDETTE, J et al.Cellular immunology (Print). 1990, Vol 127, Num 1, pp 26-34, issn 0008-8749Article

Daclizumab in treatment of multiple sclerosis patientsALI, E. N; HEALY, B. C; STAZZONE, L. A et al.Multiple sclerosis. 2009, Vol 15, Num 2, pp 272-274, issn 1352-4585, 3 p.Article

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosisGLANZ, B. I; HOLLAND, C. M; GAUTHIER, S. A et al.Multiple sclerosis. 2007, Vol 13, Num 8, pp 1004-1010, issn 1352-4585, 7 p.Article

Treatment of progressive multiple sclerosis with pulse cyclophosphamide/ methylprednisolone : Response to therapy is linked to the duration of progressive diseaseHOHOL, M. J; OLEK, M. J; ORAV, E. J et al.Multiple sclerosis. 1999, Vol 5, Num 6, pp 403-409, issn 1352-4585Article

Induction of immunity and oral tolerance to alloantigen by polymorphic class II major histocompatibility complex allopeptides in the ratSAYEGH, M. H; KHOURY, S. J; HANCOCK, W. W et al.Transplantation proceedings. 1993, Vol 25, Num 1, pp 357-358, issn 0041-1345, 1Conference Paper

Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cellsKIVISÄKK, P; HEALY, B. C; VIGLIETTA, V et al.Neurology. 2009, Vol 72, Num 22, pp 1922-1930, issn 0028-3878, 9 p.Article

Therapy for multiple sclerosisWEINER, H. L; HOHOL, M. J; KHOURY, S. J et al.Neurologic clinics. 1995, Vol 13, Num 1, pp 173-196, issn 0733-8619Article

Differential effects of oral versus intrathymic administration of polymorphic major histocompatibility complex class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity responseHANCOCK, W. W; KHOURY, S. J; CARPENTER, C. B et al.The American journal of pathology. 1994, Vol 144, Num 6, pp 1149-1158, issn 0002-9440Article

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III, Synergistic effect of lipopolysaccharideKHOURY, S. J; LIDER, O; AL-SABBAGH, A et al.Cellular immunology (Print). 1990, Vol 131, Num 2, pp 302-310, issn 0008-8749Article

Changes in activated T cells in the blood correlate with disease activity in multiple sclerosisKHOURY, S. J; GUTTMANN, C. R. G; ORAV, E. J et al.Archives of neurology (Chicago). 2000, Vol 57, Num 8, pp 1183-1189, issn 0003-9942Conference Paper

Multiple sclerosis : What have we learned from magnetic resonance imaging studies?KHOURY, S. J; WEINER, H. L.Archives of internal medicine (1960). 1998, Vol 158, Num 6, pp 565-573, issn 0003-9926Article

Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosisHOHOL, M. J; GUTTMANN, C. R. G; ORAV, J et al.Archives of neurology (Chicago). 1997, Vol 54, Num 8, pp 1018-1025, issn 0003-9942Article

Class II MHC allopeptide-specific T-cell clones transfer delayed type hypersensitivity responses in vivoWAAGA, A. M; MURPHY, B; CHEN, W et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, pp 1008-1009, issn 0041-1345Conference Paper

Mechanisms of indirect allorecognition in graft rejection : Class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivoCHEN, W; MURPHY, B; WAAGA, A. M et al.Transplantation. 1996, Vol 62, Num 6, pp 705-710, issn 0041-1337Article

ORAL TOLERANCE : immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigensWEINER, H. L; FRIEDMAN, A; MILLER, A et al.Annual review of immunology. 1994, Vol 12, pp 809-837, issn 0732-0582Article

Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the ratSAYEGH, M. H; KHOURY, S. J; HANCOCK, W. W et al.Proceedings of the National Academy of Sciences of the United States of America. 1992, Vol 89, Num 16, pp 7762-7766, issn 0027-8424Article

The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple SclerosisCECCARELLI, A; JACKSON, J. S; GUTTMANN, C. R. G et al.American journal of neuroradiology. 2012, Vol 33, Num 8, pp 1579-1585, issn 0195-6108, 7 p.Article

CTLA4Ig treatment in patients with multiple sclerosis : An open-label, phase 1 clinical trialVIGLIETTA, V; BOURCIER, K; BUCKLE, G. J et al.Neurology. 2008, Vol 71, Num 12, pp 917-924, issn 0028-3878, 8 p.Article

Predicting short-term disability in multiple sclerosisGAUTHIER, S. A; MANDEL, M; GUTTMANN, C. R. G et al.Neurology. 2007, Vol 68, Num 24, pp 2059-2065, issn 0028-3878, 7 p.Article

  • Page / 2